Arkos Global Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,463
Closed -$176K 165
2026
Q1
$176K Buy
+1,463
New +$169K 0.02% 133
2025
Q3
Sell
-3,492
Closed -$276K 169
2025
Q2
$276K Sell
3,492
-261
-7% -$20.7K 0.04% 112
2025
Q1
$337K Sell
3,753
-128
-3% -$12K 0.05% 90
2024
Q4
$386K Sell
3,881
-152
-4% -$15.7K 0.06% 81
2024
Q3
$458K Sell
4,033
-307
-7% -$36.5K 0.07% 71
2024
Q2
$537K Hold
4,340
0.09% 64
2024
Q1
$573K Sell
4,340
-507
-10% -$62.5K 0.1% 66
2023
Q4
$528K Buy
4,847
+222
+5% +$23K 0.1% 55
2023
Q3
$476K Buy
4,625
+95
+2% +$10.2K 0.1% 51
2023
Q2
$523K Buy
4,530
+237
+6% +$26.9K 0.1% 51
2023
Q1
$457K Buy
4,293
+438
+11% +$47.3K 0.09% 56
2022
Q4
$428K Buy
3,855
+399
+12% +$40.8K 0.11% 57
2022
Q3
$298K Sell
3,456
-1,185
-26% -$106K 0.09% 64
2022
Q2
$423K Buy
4,641
+1,185
+34% +$105K 0.12% 50
2022
Q1
$284K Hold
3,456
0.07% 75
2021
Q4
$265K Buy
3,456
+40
+1% +$3.19K 0.08% 75
2021
Q3
$257K Hold
3,416
0.09% 71
2021
Q2
$266K Buy
3,416
+445
+15% +$33.1K 0.09% 72
2021
Q1
$219K Buy
2,971
+20
+0.7% +$1.48K 0.08% 80
2020
Q4
$230K Hold
2,951
0.09% 71
2020
Q3
$234K Sell
2,951
-89
-3% -$6.97K 0.11% 71
2020
Q2
$224K Buy
+3,040
New +$229K 0.12% 79

Other funds holding MRK

Arkos Global Advisors's MRK Position: Q2 2026 in Review

Arkos Global Advisors sold out of Merck (MRK) in Q2 2026, closing a stake of 1,463 shares — an estimated $176K sold.

Arkos Global Advisors first reported a position in MRK in Q2 2020 and held it in 22 quarters. The position peaked at $573K in Q1 2024. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Arkos Global Advisors reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Arkos Global Advisors sold 1,463 Merck shares in Q2 2026, an estimated $176K.
  • Arkos Global Advisors first reported a position in Merck in Q2 2020 and held it in 22 quarters.
  • Arkos Global Advisors's Merck position peaked at $573K in Q1 2024.
  • 3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Arkos Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.